
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
Table of Contents
over 23 years ago
The Pivotal Prescribersover 23 years ago
Pharma-Physician Conundrumover 23 years ago
Extending the Product Lifelineover 23 years ago
How to Make Rx-Dx Alliances Work





